How Phage Therapy is Scaling to Meet Antibiotic Resistance with Jessica Sacher

A new episode of Data in Biotech is live!

Phage therapy is stepping into the spotlight as antibiotic resistance rises - and Jessica Sacher is helping lead the charge.

In this episode, Ross Katz speaks with Jessica, Co-Founder of Phage Directory and Staff Scientist at Stanford, about sourcing phages, operationalizing therapy, and predicting efficacy through data.

This conversation explores how personalized phage therapy works, its scalability, and the data challenges shaping its future.

Here’s what you’ll learn.

>> Why phage therapy is a promising solution to antibiotic-resistant infections

>> How Phage Directory connects researchers and clinicians to accelerate treatment

>> What operational hurdles exist in scaling personalized phage production

>> How data science is being applied to predict effective phage-bacteria matches

>> Why building infrastructure and awareness is essential to adoption in clinical care

Listen now wherever you find your podcasts.

Apple Podcasts: https://lnkd.in/e-c9Sg38
Spotify: https://lnkd.in/eaFm-K4j
YouTube: https://lnkd.in/ez4d3DK9

Join newsletter
Stay up to date with new case studies. We promise no spam, just good content.

More blog posts

see all